Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

Clinical trial NCT03426371 · TERMINATED

Trial details

NCT number: NCT03426371
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2018-03-18
Primary completion: 2021-11-27
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.